Scientific Reports·Nov 19Comparative cost-effectiveness of HPV mRNA and DNA testing for anal cancer screening in MSM living with HIV: a model-based studyComputational studyAnal cancerPaper
Cancers·Nov 13Fifteen Years of Progress: A Review of Cervical Cancer Care in Honduras (2010–2025)ReviewIndustry & policyPaper
Journal of Medical Screening·Oct 29Scaling up primary HPV DNA screening and self-sampling for cervical cancer in Peru: Coverage, cost-utility, and budget impact analysis using public data sourcesComputational studyCervical cancerPaper
BMC Global and Public Health·Oct 17HPV DNA testing and treatment strategies for cervical pre-cancer among women living with HIV in Papua New Guinea: a prospective clinical cohort studyCohort study of 404 peopleHPV DNAPaper
The Indian Journal of Medical Research·Oct 9Self-collected cervical samples for detection of high-risk human papillomavirus: A community outreach approach in a remote regionCohort study of 210 peopleBiomarkersPaper
Journal of Pharmacy & Bioallied Sciences·Mar 19HPV DNA Test Alone and HPV DNA Test Combined with VIA as Screening Test for Cervical CancerCross-sectional study of 400 peopleCervical cancerPaper
Taiwanese Journal of Obstetrics & Gynecology·Mar 12Genotype-specific prevalence of high-risk human papillomavirus among cytologically normal women in TaiwanCross-sectional study of 7,129 peoplePopulationsPaper
medRxiv·Feb 14Cost-effectiveness of policy options for transformation of cytology-based nationwide cervical cancer screening programme in the Czech Republic: model-based economic evaluationPreprint: computational studyIndustry & policyPaper